Back

8 July 2021

The ITA provides an update on two rule violations for weightlifters qualified for Tokyo 2020

THE INTERNATIONAL TESTING AGENCY (ITA), LEADING AN INDEPENDENT ANTI-DOPING PROGRAM FOR THE INTERNATIONAL WEIGHTLIFTING FEDERATION (IWF), PROVIDES AN UPDATE ON TWO ANTI-DOPING RULE VIOLATIONS FOR WEIGHTLIFTERS ARLEY MENDEZ PEREZ (CHILE) AND ROSA FIGUEIREDO (BRAZIL), BOTH QUALIFIED FOR THE TOKYO GAMES.

1: The World Anti-Doping Code (“Code”) defines “Substances of Abuse” as “substances that are identified as such because they are frequently abused in society outside of the context of sport. The following are designated Substances of Abuse: cocaine, diamorphine (heroin), methylenedioxymethamphetamine (MDMA/”ecstasy”), tetrahydrocannabinol (THC).” The regime of “Substance of Abuse” was introduced on 1 January 2021 with the entry of the new Code. Prior to the 2021 Code, sanctions for such cases could go up to four years depending on the circumstances. The introduction of the “Substance of Abuse” regime addresses the concerns expressed by many stakeholders during the public consultation process for the new Code whereby it transpired that where the athlete’s positive case is rather related to a drug problem than to performance enhancement, the athlete’s health should be the priority. Whilst the 2021 novelty goes in the right direction of protecting athletes and the integrity of the sport - ITA’s key mission - the ITA continuously engages with the anti-doping stakeholders, including WADA, to see how the anti-doping program can be better tailored to its objectives.
2: Since the Athlete was informed of her first AAF after providing her second sample on 31 May 2021, this case is considered as one single ADRV pursuant to Article 10.9.3.1. of the IWF ADR. 

Share

Cookie Policy & Privacy Notice

We use cookies on our website to personalize content, to analyze traffic on our website to provide social media features. We share your data with our analytics partners and social media content providers. Find out more

The privacy policy can be accessed here

Your current state: Consent rejected.


Accept Reject Read More